Open AccessPatients with a history of infection and voiding dysfunction are at risk for recurrence after successful endoscopic treatment of vesico ureteral reflux and deserve long-term follow up
Author(s) -
Riccardo Coletta,
Cláudio Olivieri,
Vito Briganti,
M. L. Perrotta,
Lucia Oriolo,
Fabio Fabbri,
Alessandro Calisti
Publication year - 2012
Publication title -
urology annals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.355
H-Index - 20
eISSN - 0974-7834
pISSN - 0974-7796
DOI - 10.4103/0974-7796.91616
Subject(s) - medicine , reflux , antibiotic prophylaxis , urinary system , univariate analysis , ureteroscopy , surgery , exact test , renal function , antibiotics , disease , multivariate analysis , ureter , microbiology and biotechnology , biology
Subureteral endoscopic injection of a bulking agent is an attractive alternative to open surgery or antibiotic prophylaxis for vesico ureteral reflux (VUR). Little information is available about long-term risk of recurrence after an initially successful treatment. Aim of this paper was to review short- and long-term success rate of endoscopic treatment in a single Center series after risk stratification of individual patients.